| Literature DB >> 20216539 |
G Andreotti1, L Hou, Y-T Gao, L A Brinton, A Rashid, J Chen, M-C Shen, B-S Wang, T-Q Han, B-H Zhang, L C Sakoda, J F Fraumeni, A W Hsing.
Abstract
BACKGROUND: Parity has been linked to gallbladder cancer and gallstones, but the effects of other reproductive factors are less clear.Entities:
Mesh:
Year: 2010 PMID: 20216539 PMCID: PMC2853091 DOI: 10.1038/sj.bjc.6605597
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640
Odds ratios (ORs) and 95% confidence intervals (CIs) for biliary stones and biliary tract cancers in relation to reproductive factors
|
|
|
| |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Total | 422 | 647 | — | — | 545 | 269 | — | — | 586 | 92 | — | — | |||
|
| |||||||||||||||
| 0 | 11 | 28 | 2.59 | (0.99–6.79) | 16 | 4 | 0.77 | (0.20–2.99) | 18 | 4 | 0.98 | (0.23–4.25) | |||
| 1 | 67 | 174 | 1 | Reference | 80 | 26 | 1 | Reference | 81 | 12 | 1 | Reference | |||
| 2 | 104 | 147 | 0.77 | (0.50–1.21) | 124 | 43 | 1.15 | (0.63–2.12) | 132 | 22 | 1 | (0.46–2.20) | |||
| 3 | 70 | 113 | 1.11 | (0.65–1.91) | 103 | 52 | 1.60 | (0.83–3.12) | 111 | 23 | 1.07 | (0.46–2.50) | |||
| 4 | 64 | 77 | 0.91 | (0.50–1.66) | 85 | 58 | 2.20 | (1.09–4.47) | 93 | 12 | 0.61 | (0.23–1.65) | |||
| 5 | 50 | 54 | 0.80 | (0.42–1.55) | 67 | 46 | 2.20 | (1.01–4.66) | 73 | 7 | 0.43 | (0.14–1.34) | |||
| ⩾6 | 56 | 53 | 0.79 | (0.40–1.56) | 70 | 39 | 1.70 | (0.75–3.74) | 78 | 12 | 0.68 | (0.23–1.98) | |||
| | 0.63 | 0.04 | 0.14 | ||||||||||||
|
| |||||||||||||||
| ⩾27 | 112 | 193 | 1 | Reference | 144 | 45 | 1 | Reference | 150 | 19 | 1 | Reference | |||
| 24–26 | 84 | 155 | 1.31 | (0.89–1.92) | 105 | 49 | 1.51 | (0.92–2.48) | 112 | 22 | 1.48 | (0.75–2.90) | |||
| 21–23 | 100 | 129 | 1.13 | (0.74–1.70) | 128 | 83 | 1.85 | (1.14–2.99) | 142 | 25 | 1.22 | (0.60–2.46) | |||
| ⩽20 | 115 | 141 | 1.10 | (0.72–1.67) | 151 | 87 | 1.48 | (0.90–2.42) | 163 | 22 | 0.91 | (0.43–1.92) | |||
| | 0.82 | 0.15 | 0.66 | ||||||||||||
|
| |||||||||||||||
| ⩽13 | 79 | 136 | 1 | Reference | 110 | 31 | 1 | Reference | 115 | 16 | 1 | Reference | |||
| 14–15 | 149 | 244 | 1.05 | (0.73–1.51) | 193 | 98 | 1.75 | (1.09–2.82) | 208 | 38 | 1.26 | (0.67–2.37) | |||
| 16–17 | 136 | 195 | 0.95 | (0.65–1.39) | 170 | 95 | 1.80 | (1.11–2.92) | 184 | 23 | 0.89 | (0.45–1.78) | |||
| ⩾18 | 58 | 70 | 0.89 | (0.55–1.43) | 72 | 41 | 1.82 | (1.03–3.24) | 79 | 14 | 1.22 | (0.55–2.72) | |||
| | 0.52 | 0.05 | 0.95 | ||||||||||||
|
| |||||||||||||||
| Postmenopausal | 381 | 518 | 1 | Reference | 500 | 245 | 1 | Reference | 540 | 85 | 1 | Reference | |||
| Premenopausal | 39 | 126 | 0.90 | (0.51–1.60) | 0.72 | 43 | 20 | 1.19 | (0.53–2.66) | 0.68 | 44 | 3 | 0.29 | (0.07–1.23) | 0.09 |
|
| |||||||||||||||
| ⩽46 | 84 | 139 | 1 | Reference | 107 | 55 | 1 | Reference | 116 | 20 | 1 | Reference | |||
| 47–49 | 113 | 148 | 0.78 | (0.53–1.14) | 158 | 83 | 1 | (0.65–1.53) | 173 | 25 | 0.78 | (0.41–1.48) | |||
| 50–52 | 120 | 160 | 0.81 | (0.57–1.17) | 152 | 76 | 0.96 | (0.62–1.48) | 164 | 28 | 0.95 | (0.51–1.79) | |||
| ⩾53 | 64 | 71 | 0.63 | (0.40–0.99) | 83 | 31 | 0.70 | (0.41–1.20) | 87 | 12 | 0.78 | (0.36–1.69) | |||
| | 0.05 | 0.20 | 0.96 | ||||||||||||
|
| |||||||||||||||
| ⩽29 | 138 | 184 | 1 | Reference | 178 | 107 | 1 | Reference | 195 | 31 | 1 | Reference | |||
| 30–32 | 111 | 143 | 0.92 | (0.65–1.30) | 149 | 63 | 0.71 | (0.48–1.04) | 159 | 19 | 0.68 | (0.37–1.27) | |||
| ⩾33 | 132 | 191 | 0.95 | (0.68–1.32) | 173 | 74 | 0.79 | (0.54–1.16) | 186 | 35 | 1.14 | (0.67–1.97) | |||
| | 0.47 | 0.09 | 0.68 | ||||||||||||
|
| |||||||||||||||
| No | 268 | 384 | 1 | Reference | 343 | 165 | 1 | Reference | 372 | 49 | 1 | Reference | |||
| Yes | 68 | 110 | 1.09 | (0.76–1.55) | 0.64 | 84 | 35 | 0.87 | (0.55–1.38) | 0.54 | 91 | 19 | 1.62 | (0.90–2.91) | 0.11 |
|
| |||||||||||||||
| Never | 28 | 76 | 1 | Reference | 39 | 22 | 1 | Reference | 41 | 13 | 1 | Reference | |||
| Ever | 383 | 542 | 0.65 | (0.40–1.06) | 0.08 | 490 | 242 | 0.73 | (0.41–1.30) | 0.29 | 527 | 75 | 0.40 | (0.20–0.81) | 0.01 |
Biliary stone cases include gallstone and bile duct stones. Biliary stone cases compared with controls without biliary stones (n=422).
Adjusted for age (continuous), education and body mass index.
Gallbladder cancer cases compared with population controls with a gallbladder (n=545).
Bile duct cancer cases compared with all population controls (n=586).
Linear test of trend using continuous variable.
Among women with at least one full-term birth (n=568 controls).
Duration of menstruation=Age at menopause–age at menarche–years of pregnancy.
Among postmenopausal women (n=540 controls).
Odds ratios (ORs) and 95% confidence intervals (CIs) for gallbladder cancer in relation to reproductive factors by biliary stone status
|
|
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total | 422 | 36 | — | — | 123 | 233 | — | — | |||||
|
| |||||||||||||
| 0 | 11 | 2 | — | — | 5 | 2 | — | — | — | — | |||
| 1 | 67 | 10 | 1 | Reference | 13 | 16 | 1 | Reference | 1 | Reference | |||
| 2 | 104 | 4 | — | — | 20 | 39 | 2.02 | (0.77–5.31) | 1.77 | (0.64–4.87) | |||
| 3 (⩾3 for no stones) | 240 | 20 | 1.21 | (0.25–5.84) | 33 | 43 | 1.35 | (0.52–3.49) | 1.23 | (0.44–3.43) | |||
| 4 | — | — | — | — | 21 | 53 | 2.89 | (1.02–8.23) | 2.55 | (0.81–8.05) | |||
| 5 | — | — | — | — | 17 | 42 | 2.86 | (0.95–8.62) | 2.38 | (0.69–8.15) | |||
| ⩾6 | — | — | — | — | 14 | 37 | 2.99 | (0.93–9.65) | 2.43 | (0.65–9.07) | |||
| | — | — | 0.57 | — | — | 0.03 | — | — | 0.16 | ||||
| | 0.09 | ||||||||||||
|
| |||||||||||||
| ⩾27 | 112 | 9 | 1 | Reference | 32 | 36 | 1 | Reference | 1 | Reference | |||
| 24–26 | 84 | 10 | 1.83 | (0.66–5.06) | 21 | 39 | 1.77 | (0.84–3.71) | 1.74 | (0.81–3.76) | |||
| 21–23 | 100 | 9 | 1.21 | (0.39–3.82) | 28 | 74 | 2.56 | (1.28–5.13) | 2.36 | (1.12–4.99) | |||
| ⩽20 | 115 | 6 | 0.59 | (0.16–2.22) | 36 | 81 | 1.96 | (0.97–3.95) | 1.86 | (0.84–4.15) | |||
| | 0.39 | 0.06 | 0.13 | ||||||||||
| | 0.07 | ||||||||||||
|
| |||||||||||||
| ⩽13 | 79 | 5 | 1 | Reference | 31 | 26 | 1 | Reference | 1 | Reference | |||
| 14–15 | 149 | 11 | 1.10 | (0.35–3.43) | 44 | 87 | 2.29 | (1.20–4.40) | 2.20 | (1.12–4.29) | |||
| 16–17 | 136 | 12 | 1.32 | (0.43–4.03) | 34 | 83 | 2.71 | (1.37–5.33) | 2.60 | (1.29–5.24) | |||
| ⩾18 | 58 | 8 | 2.33 | (0.67–8.14) | 14 | 33 | 2.61 | (1.12–6.09) | 2.28 | (0.96–5.39) | |||
| | 0.17 | 0.02 | 0.04 | ||||||||||
| | 0.86 | ||||||||||||
|
| |||||||||||||
| 0–1 and ⩾24 | — | — | — | — | 10 | 14 | 1 | Reference | — | — | |||
| 2–3 and ⩾24 | — | — | — | — | 31 | 43 | 1.47 | (0.52–4.16) | — | — | |||
| ⩾4 and ⩾24 | — | — | — | — | 12 | 18 | 1.86 | (0.49–6.94) | — | — | |||
| 0–1 and ⩽23 | — | — | — | — | 2 | 2 | — | — | |||||
| 2–3 and ⩽23 | — | — | — | — | 22 | 39 | 1.77 | (0.59–5.20) | — | — | |||
| ⩾4 and ⩽23 | — | — | — | — | 40 | 114 | 3.26 | (1.06–10.03) | — | — | |||
|
| |||||||||||||
| 0–1 and ⩽15 | — | — | — | — | 12 | 12 | 1 | Reference | — | — | |||
| 2–3 and ⩽15 | — | — | — | — | 37 | 44 | 1.48 | (0.49–4.40) | — | — | |||
| ⩾4 and ⩽15 | — | — | — | — | 26 | 57 | 3.19 | (0.95–10.69) | — | — | |||
| 0–1 and ⩾16 | — | — | — | — | 6 | 6 | 1.12 | (0.21–6.09) | — | — | |||
| 2–3 and ⩾16 | — | — | — | — | 16 | 36 | 2.56 | (0.79–8.21) | — | — | |||
| ⩾4 and ⩾16 | — | — | — | — | 26 | 74 | 4.01 | (1.19–13.58) | — | — | |||
Gallbladder cancer cases compared with population controls with a gallbladder (n=545).
Adjusted for age (continuous), education and body mass index.
Further adjusted for age first birth (continuous), age menarche (continuous) and parity; each factor is not self-adjusted.
Linear test of trend using continuous variable.
Among women with at least one full-term birth (n=568 controls).